Biogen (BIIB) Tops Q1 EPS by 14c
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $219.05 +1.41%
EPS Growth %: -57.8%
Financial Fact:
Total revenues: 2.96B
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -57.8%
Financial Fact:
Total revenues: 2.96B
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $6.98, $0.14 better than the analyst estimate of $6.84. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.39 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Biogen's Empaveli cuts proteinuria 75% in teens with rare kidney disease
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
